FBLGFibroBiologics Inc. Common Stock

1.440USD+21.01%Mkt Cap: 9.59M $P/E:

FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline in…